BCTG Acquisition Corp (BCTG)

Etorro trading 970x250

About BCTG Acquisition Corp

BCTG Acquisition Corp. intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses primarily located in North America and Europe in the biotechnology industry. The company was founded in 2020 and is based in San Diego, California. Address: 11682 El Camino Real, San Diego, CA, United States, 92130

BCTG Acquisition Corp News and around…

Latest news about BCTG Acquisition Corp (BCTG) common stock and company :

Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies
10 Aug, 2021 FinancialContent
August SPAC Merger Vote Calendar: A Look At Upcoming Votes And Stocks To Watch
07 Aug, 2021 FinancialContent

The months of June and July were among the busiest for SPAC merger votes so far in 2021.August is now filling up with several deal ...

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BCTG Acquisition Corp. Merger
22 Apr, 2021 FinancialContent
SPACs Attack Recap: 5 Deals, Rumors And Headline News
18 Apr, 2021 FinancialContent

It was another busy week for the SPAC market with numerous deal announcements and rumored deals. Benzinga's "SPACs Attack" ...

42 Biggest Movers From Yesterday
16 Apr, 2021 FinancialContent

Gainers Esports Technologies, Inc. (NASDAQ: EBET) shares jumped 507% to settle at $36.42 on Thursday. agilon health, inc. (NYSE: ...

30 Stocks Moving In Thursday's Mid-Day Session
15 Apr, 2021 FinancialContent

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 58.2% to $13.16 after gaining 14% on Wednesday. The ...

Cancer Biotech Tango Therapeutics Picks Boxer Capital's SPAC To Go Public Via $353M Merger
14 Apr, 2021 FinancialContent

The latest biotech-SPACdeal has arrived with Cambridge, Massachusetts-basedTango Therapeuticsannouncing ...

Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies
14 Apr, 2021 FinancialContent

Tango Therapeutics, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, and BCTG Acquisition Corp. (Nasdaq: BCTG), a special purpose acquisition company (SPAC) sponsored by Boxer Capital, today announced they have entered into a definitive merger agreement. Upon closing of the transaction, the company will be named Tango Therapeutics, Inc. (Combined Company) and will be led by Barbara Weber, MD, President and Chief Executive Officer of Tango. Tango Therapeutics, Inc. common stock is expected to be listed on Nasdaq under the ticker symbol “TNGX”.

BCTG Acquisition Corp (BCTG) is a NASDAQ Common Stock listed in , ,

970x250